Molecular characteristics of pbp1a and pbp2b in clinical Streptococcus pneumoniae isolates in Quebec, Canada

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 1, 2006, Pages 61-70

  Granger, Dominic ^a,b   Boily Larouche, Geneviève ^a   Turgeon, Pierre ^b,c   Weiss, Karl ^b,d   Roger, Michael ^a,b  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

lactams; Cefotaxime resistance; Penicillin resistance; Penicillin binding proteins; Pneumococci; Serotypes

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFUROXIME; GAMMA GLUTAMYLTRANSFERASE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 1A; PENICILLIN BINDING PROTEIN 2B; PENICILLIN G; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BIOLOGICAL MONITORING; CANADA; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA FINGERPRINTING; DNA SEQUENCE; GEOGRAPHIC DISTRIBUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIN RESISTANCE; PREVALENCE; PROTEIN MOTIF; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID MOTIFS; AMINOACYLTRANSFERASES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CANADA; CHILD, PRESCHOOL; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PENICILLIN RESISTANCE; PENICILLIN-BINDING PROTEINS; PEPTIDYL TRANSFERASES; PNEUMOCOCCAL INFECTIONS; SEQUENCE ANALYSIS, PROTEIN; STREPTOCOCCUS PNEUMONIAE;

EID: 30344448297     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki401     Document Type: Article

References (38)

1. Felmingham D, Gruneberg RN. The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000; 45: 191-203.
2. Song JH, Lee NY, Ichiyama S et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 1999; 28: 1206-11.
3. Oteo J, Alos JI, Gomez-Garces JL. Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: A multicentre surveillance study. J Antimicrob Chemother 2001; 47: 215-18.
4. Zhanel GG, Palatnick L, Nichol KA et al. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003; 47: 1867-74.
5. Zhanel GG, Karlowsky JA, Palatnick L et al. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group. Antimicrob Agents Chemother 1999; 43: 2504-9.
6. Grebe T, Hakenbeck R. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of β-lactam antibiotics. Antimicrob Agents Chemother 1996; 40: 829-34.
7. Krauss J, van der LM, Grebe T et al. Penicillin-binding proteins 2x and 2b as primary PBP targets in Streptococcus pneumoniae. Microb Drug Resist 1996; 2: 183-6.
8. Dowson CG, Johnson AP, Cercenado E et al. Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible. Antimicrob Agents Chemother 1994; 38: 49-53.
9. Munoz R, Dowson CG, Daniels M et al. Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1992; 6: 2461-5.
10. Reichmann P, Konig A, Marton A et al. Penicillin-binding proteins as resistance determinants in clinical isolates of Streptococcus pneumoniae. Microb Drug Resist 1996; 2: 177-81.
11. Coffey TJ, Daniels M, McDougal LK et al. Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1995; 39: 1306-13.
12. Granger D, Boily-Larouche G, Turgeon P et al. Genetic analysis of pbp2x in clinical Streptococcus pneumoniae isolates in Quebec, Canada. J Antimicrob Chemother 2005; 55: 832-9.
13. Baek JY, Ko KS, Oh WS et al. Unique variations of pbp2b sequences in penicillin-nonsusceptible Streptococcus pneumoniae isolates from Korea. J Clin Microbiol 2004; 42: 1746-50.
14. Sa-Leao R, Vilhelmsson SE, de Lencastre H et al. Diversity of penicillin-nonsusceptible Streptococcus pneumoniae circulating in Iceland after the introduction of penicillin-resistant clone Spain(6B)-2. J Infect Dis 2002; 186: 966-75.
15. Ferroni A, Berche P. Alterations to penicillin-binding proteins 1A, 2B and 2X amongst penicillin-resistant clinical isolates of Streptococcus pneumoniae serotype 23F from the nasopharyngeal flora of children. J Med Microbiol 2001; 50: 828-32.
16. Dowson CG, Hutchison A, Brannigan JA et al. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1989; 86: 8842-6.
17. Overweg K, Bogaert D, Sluijter M et al. Molecular characteristics of penicillin-binding protein genes of penicillin-nonsusceptible Streptococcus pneumoniae isolated in the Netherlands. Microb Drug Resist 2001; 7: 323-34.
18. Smith AM, Klugman KP. Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 1995; 39: 859-67.
19. Ubukata K, Asahi Y, Yamane A et al. Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. J Clin Microbiol 1996; 34: 592-6.
20. Yamane A, Nakano H, Asahi Y et al. Directly repeated insertion of 9-nucleotide sequence detected in penicillin-binding protein 2B gene of penicillin-resistant Streptococcus pneumoniae: Antimicrob Agents Chemother 1996; 40: 1257-9.
21. duPlessis M, Bingen E, Klugman KP. Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin. Antimicrob Agents Chemother 2002; 46: 2349-57.
22. Nagai K, Davies TA, Jacobs MR et al. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Antimicrob Agents Chemother 2002; 46: 1273-80.
23. Laible G, Spratt BG, Hakenbeck R. Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Mol Microbiol 1991; 5: 1993-2002.
24. Dowson CG, Coffey TJ, Kell C et al. Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae. Mol Microbiol 1993; 9: 635-43.
25. Nichol KA, Zhanel GG, Hoban DJ. Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 2002; 46: 3261-64.
26. Pagliero E, Chesnel L, Hopkins J et al. Biochemical characterization of Streptococcus pneumoniae penicillin-binding protein 2b and its implication in β-lactam resistance. Antimicrob Agents Chemother 2004; 48: 1848-55.
27. Herzberg O, Moult J. Bacterial resistance to β-lactam antibiotics: crystal structure of β-lactamase from Staphylococcus aureus PC1 at 2.5 Å resolution. Science 1987; 236: 694-701.
28. Sanbongi Y, Ida T, Ishikawa M et al. Complete sequences of six penicillin-binding protein genes from 40 Streptococcus pneumoniae clinical isolates collected in Japan. Antimicrob Agents Chemother 2004; 48: 2244-50.
29. Dowson CG, Hutchison A, Spratt BG. Extensive re-modelling of the transpeptidase domain of penicillin binding protein 2B of a penicillin-resistant South African isolate of Streptococcus pneumoniae. Mol Microbiol 1989; 3: 95-102.
30. Asahi Y, Ubukata K. Association of a Thr-371 substitution in a conserved amino acid motif of penicillin-binding protein 1A with penicillin resistance of Streptococcus pneumoniae: Antimicrob Agents Chemother 1998; 42: 2267-73.
31. Martin C, Sibold C, Hakenbeck R. Relatedness of penicillin-binding protein 1a genes from different clones of penicillin-resistant Streptococcus pneumoniae isolated in South Africa and Spain. EMBO J 1992; 11: 3831-6.
32. Smith AM, Klugman KP. Alterations in PBP 1A essential for high-level penicillin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 1998; 42: 1329-33.
33. Smith AM, Klugman KP. Site-specific mutagenesis analysis of PBP 1A from a penicillin-cephalosporin-resistant pneumococcal isolate. Antimicrob Agents Chemother 2003; 47: 387-9.
34. Chalkley LJ, Koornhof HJ. Intra- and inter-specific transformation of Streptococcus pneumoniae to penicillin resistance. J Antimicrob Chemother 1990; 26: 21-8.
35. Krauss J, Hakenbeck R. A mutation in the D,D-carboxypeptidase penicillin-binding protein 3 of Streptococcus pneumoniae contributes to cefotaxime resistance of the laboratory mutant C604. Antimicrob Agents Chemother 1997; 41: 936-42.
36. Guenzi E, Gasc AM, Sicard MA et al. A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae. Mol Microbiol 1994; 12: 505-15.
37. Grebe T, Paik J, Hakenbeck R. A novel resistance mechanism against β-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferase. J Bacteriol 1997; 179: 3342-9.
38. Smith AM, Klugman KP. Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 2001; 45: 2393-6.